Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI7183 in Japanese Ulcerative Colitis
NCT01959165Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2013
- Primary completion
- Aug 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of abrilumab in ulcerative colitis (UC), sponsored by AstraZeneca. Started Nov 2013; status: completed.
02
Drugs
abrilumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01959165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959165.